Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment [NA]
Clinical trial results posted on using hyperbaric oxygen therapy to improve umbilical cord blood stem cell homing and engraftment in patient…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas [Phase 2]
Phase 2 trial update evaluating intratumoral PF-3512676 plus local radiation in low-grade Non-Hodgkin lymphoma, including follicular/indolen…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders [Phase 2]
Phase 2 trial evaluating myeloablative conditioning with hyperfractionated total body irradiation plus thiotepa and fludarabine followed by …
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hema…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia [NA]
A pediatric oncology trial evaluated yoga to alleviate fatigue, anxiety, and pain in adolescents undergoing treatment for leukemia or lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant [Phase 2]
Phase 2 trial of T-cell replete haploidentical donor hematopoietic stem cell transplantation with natural killer (NK) cell support in hemato…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of ANGEL, an EBV-specific cytotoxic T-cell therapy for relapsed Epstein…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [Phase 1, Phase 2]
Phase 1 and Phase 2 results are reported for allogeneic cytokine-induced killer (CIK) cell immunotherapy given to patients who relapsed afte…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: AMG 319 Lymphoid Malignancy FIH [Phase 1]
First-in-human Phase 1 clinical trial update for AMG 319 in lymphoid malignancies, including chronic lymphocytic leukemia and various lympho…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients [NA]
A completed clinical trial evaluating the effectiveness of the neutropenic diet in pediatric oncology patients, including acute lymphoblasti…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a conditioning regimen with Iodine-131 tositumomab plus etoposide and cyclophosphamide, followed by autolo…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allogeneic Transplantation From Related Haploidentical Donors [Phase 2]
A Phase 2 clinical trial evaluating allogeneic transplantation from related haploidentical donors for blood cancers and leukemia has complet…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas [Phase 1]
Phase 1 study evaluating CHOP chemotherapy plus Campath-1H (alemtuzumab) as initial treatment for untreated aggressive T/NK-cell non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating combination chemotherapy plus Rituximab and radiation therapy in patients with Stage I or Stage II Non-Hodgkin's …
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Safety Study of HBI-8000 in Japanese Patients With Non Hodgkin's Lymphoma [Phase 1]
Phase 1 safety study evaluating HBI-8000 in Japanese patients with Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of LBH589 (panobinostat) in patients with recurrent or refractory Hodgkin lymphoma or non-Hodgkin lymphoma has been terminated…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating a combination of bortezomib, rituximab, and yttrium-90 ibritumomab tiuxetan in relapsed or refractory low-grade, fo…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial assesses the effectiveness of fludarabine plus octreotide in patients with relapsed low-grade Non-Hodgkin lymphoma. The s…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT
A retrospective analysis of patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma treated with Z-BEAM conditioning follow…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating rituximab plus cladribine for newly diagnosed non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy with rituximab for relapsed non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma [Phase 1]
An early-phase (Phase I/II) study of Abraxane in recurrent and refractory lymphoma was terminated. The trial involved non-Hodgkin lymphoma a…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) [Phase 2]
Phase 2 trial assessing blood stem cell transplant with low-dose chemotherapy for relapsed follicular non-Hodgkin's lymphoma (BMT CTN 0701) …
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) [Phase 4]
Phase 4 expanded access program update for pegfilgrastim (Neulastim) in participants with non-Hodgkin's lymphoma, now completed.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT) [Phase 1]
Phase 1 trial update of immunostimulatory CpG SD-101 plus radiation therapy for recurrent/progressive lymphoma after allogeneic hematopoieti…